Copyright: Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.! 京ICP备19006400号-1 Powered by 300.cn
美科
Links:
Stemedica Cell Technologies, Inc., a US company with investment from JZT, reported remarkable benefits in a study using MSCs to treat 8 COVID-19 patients.
Source:
Release time:
2020/07/28 14:10
Page view
Stemedica Cell Technologies, Inc., a US company with investment from JZT, reported remarkable benefits in a study using MSCs to treat 8 COVID-19 patients.